Javascript must be enabled to continue!
Clinical Features of Systemic Lupus Erythematosus-related Interstitial Lung Disease-a Clinical Retrospective Study
View through CrossRef
Abstract
Background: There is no conclusion about the correlation between autoantibodies in SLE patients and ILD. In order to help early diagnosis of SLE-ILD, here we will compare the differences in clinical data of SLE-ILD and SLE-NILD patients and explore the clinical features of SLE-ILD and the value of indicators related to the diagnosis of SLE-ILD and independent risk factors. Methods: A clinical retrospective study. Select 89 SLE-ILD patients and 187 SLE-NILD patients, collect all patients' age of onset, smoking history, sex, and autoantibodies, and compare the differences between the two. Additionally collect respiratory manifestations, pulmonary auscultation signs, pulmonary computer tomography and pulmonary function of SLE-ILD patients. Rely on the above clinical data to carry out relevant summary and statistical analysis, and explore the correlation between pulmonary function and autoantibodies in SLE-ILD patients, the value of autoantibodies in the diagnosis of SLE-ILD and the independent risk factors of SLE-ILD. Results:SLE-ILD patients have a higher ANA positive rate than SLE-NILD patients. There is no correlation found between pulmonary function indexes and autoantibodies in SLE-ILD patients. The diagnostic sensitivity of ANA for SLE-ILD is 97.8%, specificity only 3.2%. The diagnostic sensitivity and specificity of Ro-52 are 61.8% and 52.9%. Age, ANA, SM, and Ro-52 are independent risk factors for the onset of SLE-ILD.Conclusions: Age, ANA, SM, and Ro-52 are meaningful and notable indicators for SLE patients when in doubt whether they are accompanied by ILD.
Title: Clinical Features of Systemic Lupus Erythematosus-related Interstitial Lung Disease-a Clinical Retrospective Study
Description:
Abstract
Background: There is no conclusion about the correlation between autoantibodies in SLE patients and ILD.
In order to help early diagnosis of SLE-ILD, here we will compare the differences in clinical data of SLE-ILD and SLE-NILD patients and explore the clinical features of SLE-ILD and the value of indicators related to the diagnosis of SLE-ILD and independent risk factors.
Methods: A clinical retrospective study.
Select 89 SLE-ILD patients and 187 SLE-NILD patients, collect all patients' age of onset, smoking history, sex, and autoantibodies, and compare the differences between the two.
Additionally collect respiratory manifestations, pulmonary auscultation signs, pulmonary computer tomography and pulmonary function of SLE-ILD patients.
Rely on the above clinical data to carry out relevant summary and statistical analysis, and explore the correlation between pulmonary function and autoantibodies in SLE-ILD patients, the value of autoantibodies in the diagnosis of SLE-ILD and the independent risk factors of SLE-ILD.
Results:SLE-ILD patients have a higher ANA positive rate than SLE-NILD patients.
There is no correlation found between pulmonary function indexes and autoantibodies in SLE-ILD patients.
The diagnostic sensitivity of ANA for SLE-ILD is 97.
8%, specificity only 3.
2%.
The diagnostic sensitivity and specificity of Ro-52 are 61.
8% and 52.
9%.
Age, ANA, SM, and Ro-52 are independent risk factors for the onset of SLE-ILD.
Conclusions: Age, ANA, SM, and Ro-52 are meaningful and notable indicators for SLE patients when in doubt whether they are accompanied by ILD.
Related Results
Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus
Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus
Background Cutaneous involvement is very common in systemic lupus erythematosus. We describe the prevalence and spectrum of lupus-specific (cutaneous lupus erythematosus) and non-s...
Crucial Role of Foxp3 Gene Expression and Mutation in Systemic Lupus Erythematosus, Inferred from Computational and Experimental Approaches
Crucial Role of Foxp3 Gene Expression and Mutation in Systemic Lupus Erythematosus, Inferred from Computational and Experimental Approaches
The impaired suppressive function of regulatory T cells is well-understood in systemic lupus erythematosus. This is likely due to changes in Foxp3 expression that are crucial for r...
BRIEF REVIEW ABOUT NEUROLOGICAL, HEMATOLOGICAL, GASTROINTESTINAL, CARDIOVASCULAR AND PULMONAR MANIFESTATIONS OF SYSTEMIC ERYTHEMATOSUS LUPUS
BRIEF REVIEW ABOUT NEUROLOGICAL, HEMATOLOGICAL, GASTROINTESTINAL, CARDIOVASCULAR AND PULMONAR MANIFESTATIONS OF SYSTEMIC ERYTHEMATOSUS LUPUS
Systemic Lupus Erythematosus is an autoimmune multisystem pathology, characterized by being more prevalent in women, especially African women. One of the most frequent pathologies ...
Histology of Skin Alterations in Lupus Erythematosus
Histology of Skin Alterations in Lupus Erythematosus
Abstract
Lupus erythematosus is an autoimmune connective tissue disorder showing a broad spectrum of clinical manifestations.
The a...
Unravelling treatment efficacy and failure in systemic lupus erythematosus
Unravelling treatment efficacy and failure in systemic lupus erythematosus
<p dir="ltr">Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple organ systems with varying severity and presents with unpredictable patt...
Unravelling treatment efficacy and failure in systemic lupus erythematosus
Unravelling treatment efficacy and failure in systemic lupus erythematosus
<p dir="ltr">Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple organ systems with varying severity and presents with unpredictable patt...
The co-occurrence of Kikuchi–Fujimoto disease and systemic lupus erythematosus: a case report
The co-occurrence of Kikuchi–Fujimoto disease and systemic lupus erythematosus: a case report
Abstract
Background
Kikuchi–Fujimoto disease is an uncommon systemic disease that mostly affects young women. Kikuchi–Fujimoto disease typically man...
SYSTEMIC LUPUS ERYTHEMATOSUS: UPDATE ΟN THE DIAGNOSIS, PREVALENCE, CLINICAL MANAGEMENT, INFLAMMATORY MARKERS, NEW HORIZONS IN THE PATHOGENESIS, MANIFESTATIONS AND PROGRESS IN TREATMENT
SYSTEMIC LUPUS ERYTHEMATOSUS: UPDATE ΟN THE DIAGNOSIS, PREVALENCE, CLINICAL MANAGEMENT, INFLAMMATORY MARKERS, NEW HORIZONS IN THE PATHOGENESIS, MANIFESTATIONS AND PROGRESS IN TREATMENT
Introduction: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multisystem involvement, generating chronic inflammation and damage of more than one organ. I...

